Exploring High Growth Tech Stocks in the United States December 2024

Over the last 7 days, the United States market has dropped 1.1%, yet it has risen by an impressive 22% over the past year, with earnings forecasted to grow by 15% annually. In this context of fluctuating short-term performance and promising long-term growth, identifying high growth tech stocks requires a focus on companies with strong innovation potential and robust financial health to capitalize on future opportunities.

Top 10 High Growth Tech Companies In The United States

Name	Revenue Growth	Earnings Growth	Growth Rating
Super Micro Computer	24.13%	24.28%	★★★★★★
Ardelyx	25.47%	69.63%	★★★★★★
Alnylam Pharmaceuticals	22.34%	70.30%	★★★★★★
Sarepta Therapeutics	24.07%	43.17%	★★★★★★
Alkami Technology	21.99%	102.65%	★★★★★★
Clene	77.61%	59.19%	★★★★★★
TG Therapeutics	34.86%	56.98%	★★★★★★
Travere Therapeutics	31.70%	72.51%	★★★★★★
Seagen	22.57%	71.80%	★★★★★★
ImmunoGen	26.00%	45.85%	★★★★★★

Click here to see the full list of 236 stocks from our US High Growth Tech and AI Stocks screener.

Let's dive into some prime choices out of from the screener.

Pagaya Technologies (NasdaqCM:PGY)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pagaya Technologies Ltd. is a technology company that utilizes data science and proprietary AI technology to serve financial institutions and investors globally, with a market cap of approximately $710.78 million.

Operations: Pagaya Technologies Ltd. generates its revenue primarily from the Software & Programming segment, amounting to $970.90 million. The company leverages its proprietary AI technology and data science to offer solutions tailored for financial institutions across various regions, including the United States and Israel.

Pagaya Technologies, navigating through a challenging landscape marked by unprofitability and significant insider selling over the past three months, is poised for a turnaround with projections of profitability within the next three years. The company's revenue growth at 15.5% annually outpaces the US market average of 9.2%, signaling robust potential in its sector. Recent strategic board appointments and a successful $600 million financing round underscore its commitment to leveraging AI in consumer credit markets, further enhancing its growth trajectory amidst operational adjustments aimed at governance and executive leadership enhancement.

• Navigate through the intricacies of Pagaya Technologies with our comprehensive health report here.

• Explore historical data to track Pagaya Technologies' performance over time in our Past section.

AVITA Medical (NasdaqCM:RCEL)

Simply Wall St Growth Rating: ★★★★★☆

Overview: AVITA Medical, Inc. is a regenerative medicine company that develops and commercializes innovative therapies for skin restoration in the United States and internationally, with a market cap of $354.12 million.

Operations: AVITA Medical generates revenue primarily from its Recell Devices, totaling $60.04 million.

AVITA Medical's recent FDA approvals and strategic product launches, such as RECELL GO mini and Cohealyx, underscore its innovative approach to the treatment of full-thickness wounds. With a 35.7% annual revenue growth and an anticipated shift to profitability within three years, AVITA is navigating its way through the competitive landscape of biotech innovations. The company's focus on expanding its portfolio in wound care solutions not only meets a critical market need but also positions it for sustained growth, leveraging advanced technologies to improve patient outcomes significantly.

• Delve into the full analysis health report here for a deeper understanding of AVITA Medical.

• Review our historical performance report to gain insights into AVITA Medical's's past performance.

Crane NXT (NYSE:CXT)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Crane NXT, Co. is an industrial technology company focused on delivering solutions for securing, detecting, and authenticating critical assets for its customers, with a market capitalization of approximately $3.32 billion.

Operations: Crane NXT generates revenue primarily through its two segments: Crane Payment Innovations, which contributes $873.40 million, and Security and Authentication Technologies, accounting for $571.20 million.

Crane NXT's strategic maneuvers, including the recent acquisition of Smart Packaging assets from TruTag Technologies, underscore its commitment to diversifying and securing its market position through innovative technologies. With a 13.1% annual revenue growth and an earnings forecast to grow by 23.3% annually, Crane NXT is actively expanding its capabilities in secure packaging solutions. This approach not only enhances product authenticity but also positions the company favorably within the tech-driven security sector, particularly as it targets becoming a $3 billion entity by 2028. The firm's robust pursuit of mergers and acquisitions, as indicated by multiple statements from CEO Aaron Saak about maintaining a healthy M&A funnel, reflects a proactive strategy to foster growth and resilience amidst dynamic market demands.

• Dive into the specifics of Crane NXT here with our thorough health report.

• Understand Crane NXT's track record by examining our Past report.

Turning Ideas Into Actions

• Reveal the 236 hidden gems among our US High Growth Tech and AI Stocks screener with a single click here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com